News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
US Approves Pfizer Inc. Generic of Novartis AG Genotropin
September 3, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ZURICH, Sept 3 (Reuters) - U.S. regulators approved Novartis AG's Omnitrope Pen 10 with liquid cartridge, a copy-cat version of Pfizer Inc's human growth hormone Genotropin.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
Pfizer
Novartis
MORE ON THIS TOPIC
Approvals
AstraZeneca wins nod for blood pressure pill, opening new class of hypertension drugs
May 18, 2026
·
1 min read
·
Tristan Manalac
Government
Prasad ally Szarama exits CBER after 3 weeks as FDA cleanout continues
May 18, 2026
·
1 min read
·
Tristan Manalac
FDA
Interim CDER head Høeg is out days after Makary: report
May 15, 2026
·
2 min read
·
Gabrielle Masson
Regulatory
Future of Aardvark’s Prader-Willi drug in doubt as FDA slaps full hold on program
May 15, 2026
·
2 min read
·
Tristan Manalac
